MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
GliaPharm
GliaPharm

GliaPharm is a Swiss-based startup company that develops treatments for neurological and psychiatric disorders. Our company is a spinoff from a leading research laboratory at EPFL. GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to enhance neuroprotection in pathological conditions. Our vision is to become a leading biotech company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
GliaPharm is a Swiss-based biotech startup company, spinoff from EPFL, that develops innovative treatments for neurological disorders

Connect with GliaPharm

2017

2017 Finalist Switzerland

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.